TY - JOUR T1 - The Common LncRNAs of Neuroinflammation-Related Diseases JF - Molecular Pharmacology JO - Mol Pharmacol SP - 113 LP - 131 DO - 10.1124/molpharm.122.000530 VL - 103 IS - 3 AU - Meixing Zeng AU - Ting Zhang AU - Yan Lin AU - Yongluan Lin AU - Zhuomin Wu Y1 - 2023/03/01 UR - http://molpharm.aspetjournals.org/content/103/3/113.abstract N2 - Spatio-temporal specific long noncoding RNAs (lncRNAs) play important regulatory roles not only in the growth and development of the brain but also in the occurrence and development of neurologic diseases. Generally, the occurrence of neurologic diseases is accompanied by neuroinflammation. Elucidation of the regulatory mechanisms of lncRNAs on neuroinflammation is helpful for the clinical treatment of neurologic diseases. This paper focuses on recent findings on the regulatory effect of lncRNAs on neuroinflammatory diseases and selects 10 lncRNAs that have been intensively studied to analyze their mechanism action. The clinical treatment status of lncRNAs as drug targets is also reviewed.SIGNIFICANCE STATEMENT Gene therapies such as clustered regularly interspaced short palindrome repeats technology, antisense RNA technology, and RNAi technology are gradually applied in clinical treatment, and the development of technology is based on a large number of basic research investigations. This paper focuses on the mechanisms of lncRNAs regulation of neuroinflammation, elucidates the beneficial or harmful effects of lncRNAs in neurosystemic diseases, and provides theoretical bases for lncRNAs as drug targets. ER -